Project Grant R43JG000004
Award Date 9/30/25
Completion Date 3/31/26
Dollars Obligated $266K
Funding Federal Agency
Awarding Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Wyoming, USA
Similar Awards
- The Centers for Disease Control and Prevention (CDC) awarded a $300,000 Project Grant to Pace Diagnostics, Inc. under the CDC Investigations and Technical Assistance program (CFDA 93.283). The funding will support the development of an ultrasensitive urine tuberculosis (TB) antigen rapid detection test for the diagnosis of active TB. The project period is from Sep 30, 2025 to Mar 31, 2026. The CDC Investigations and Technical Assistance program funds research, surveillance, epidemiological...
- The U.S. Centers for Disease Control and Prevention (CDC) awarded a $233,666 Project Grant to Esper Biosciences Inc. in Ithaca, NY on September 30, 2025 under the CDC Investigations and Technical Assistance program (CFDA 93.283). The grant funding supports the development of a rapid point-of-care nucleic acid test for Hepatitis C using nanosensors. This project aligns with the CDC program's goals of controlling communicable diseases and developing innovative health technologies. The award has...
- The U.S. Centers for Disease Control and Prevention (CDC) awarded a $1,047,807 Project Grant under the CDC Investigations and Technical Assistance program (CFDA 93.283) to Nanohmics Inc., a small technology development company based in Austin, TX. The grant, with a performance period from September 30, 2025 to September 29, 2027, supports the development of Lateral Flow-Electrochemiluminescent (LF-ECL) test strips and a portable reader system for ultrasensitive detection of foodborne...
- The U.S. Centers for Disease Control and Prevention (CDC) awarded a $279,270 Project Grant to Advanced Virology Inc. in Philadelphia, PA on September 30, 2025. The grant, funded through the CDC's Investigations and Technical Assistance program (CFDA 93.283), supports the development of "LOW-COST AND HIGH EFFICIENCY DNA-BASED REVERSE GENETICS PLATFORMS FOR MANUFACTURING RNA VIRUS PRODUCTS." The project aims to advance technologies for the production of RNA virus-based products through...
- The Centers for Disease Control and Prevention (CDC) awarded Seacoast Science, Inc. a $541,648 Project Grant under the CDC Investigations and Technical Assistance program (CFDA 93.283) on September 30, 2025. The purpose of this award is to develop an auto-calibrating air quality monitoring system. Seacoast Science, Inc. is a for-profit company that specializes in advanced chemical sensors, detection devices, and monitoring systems, with a focus on innovative environmental and safety monitoring...
- This $994,658 Project Grant was awarded on September 30, 2025 by the Centers for Disease Control and Prevention (CDC) under the Investigations and Technical Assistance program (CFDA 93.283) to Lo Biosciences, Inc., a minority-owned biotechnology company based in Rockville, Maryland. The award supports the development of a novel remote blood separation device for at-home plasma collection to enable HIV-1 testing. This project aims to create an innovative diagnostic technology that improves the...
- The U.S. Centers for Disease Control and Prevention (CDC) awarded a $501,200 Project Grant on Sep 30, 2025 to Aptus Biosciences LLC, a minority-owned small business located in Gainesville, Florida, under the CDC's "Prevention of Disease, Disability, and Death by Infectious Diseases" program (CFDA 93.084). The funding will support the development of a rapid, affordable, aptamer-based diagnostic test for Hepatitis C virus. Aptus Biosciences specializes in advanced diagnostic research and...
- This $288,023 federal Project Grant was awarded by the Centers for Disease Control and Prevention (CDC) under the Investigations and Technical Assistance program (CFDA 93.283). The grant was awarded on July 1, 2025 to the University of Vermont & State Agricultural College to study the feasibility and acceptability of tele-exercise to improve physical function in World Trade Center responders with prostate cancer. The funding will support research, surveillance, and technical assistance...
- The Project Grant award titled "FEV1 VARIABILITY AS A NOVEL MORTALITY BIOMARKER" was provided by the Centers for Disease Control and Prevention (CDC) Investigations and Technical Assistance program (CFDA 93.283) to New York University School of Medicine. The $262,731 award, which began on July 1, 2025, supports research to investigate FEV1 variability as a novel biomarker for mortality. This award is part of the CDC's broader program to fund public health initiatives focused on...
- The Centers for Disease Control and Prevention (CDC) awarded a $249,999 Project Grant under the CDC Investigations and Technical Assistance program (CFDA 93.283) to New York University (NYU) to explore the impact of body mass index and health disparities on lung function trajectories in World Trade Center survivors. The award period runs from July 1, 2025 to June 30, 2027. The project aims to develop innovative approaches to address critical public health challenges and strengthen disease...